LeMaitre Q2 2023 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/8/2026
- US stock futures tumble as Trump says Iran deal is 'over', oil climbs
- Oil jumps over 4% to two-week high after Trump says deal with Iran 'over'
- Nvidia is up just 3% YTD while SOX surges 82% — what’s holding it back?
- BofA says S&P 500 technicals point to corrective Q3
- Alibaba rallies 12% after report of narrowing losses sparks pre-earnings optimism
- Morgan Stanley Reiterates Overweight Rating on Rocket Lab USA (RKLB), Bull Case Raised to $293
- Fiserv president resigns, interim leaders named for financial unit
- Nasdaq sinks as AI worries hit chipmakers
- Amazon launches bond sale seeking at least $25 billion
- Raymond James Starts SpaceX (SPCX) at Strong Buy, PT Street High $800
Lemaitre Vascular (LMAT) Tops Q2 EPS by 4c, Beats on Revenue; Offers FY23 Guidance
August 1, 2023 4:26 PM EDTLemaitre Vascular (NASDAQ: LMAT) reported Q2 EPS of $0.36, $0.04 better than the analyst estimate of $0.32. Revenue for the quarter came in at $50.1 million versus the consensus estimate of $48.08 million.
GUIDANCE:
Lemaitre Vascular sees FY2023 EPS of $1.25-$1.35, versus the consensus of... More
